Clinical value of myocardial contrast echocardiography in chronic coronary artery disease.
Myocardial contrast echocardiography (MCE) has become a major field of clinical research in echocardiography in the last decade. The introduction of new contrast agents was accompanied by a large variety of new contrast specific imaging techniques. Recent experimental and clinical studies demonstrate that MCE is now ready for clinical applications. We report our clinical experience for diagnosis of coronary artery disease (CAD) and in particular, first experimental and clinical results with SonoVue, a new echo contrast agent.